Medically reviewed by Dr Sin Yong · Last reviewed · Doctor-performed, never delegated · Jump to questions
Ellanse Singapore in brief: Ellansé (known as 少女针 in Chinese) is a polycaprolactone (PCL) filler and collagen stimulator: a gel carrier that is absorbed, leaving microspheres that prompt your own collagen. It cannot be dissolved, so Dr Sin Yong maps earlier filler with ultrasound first and places it deep, in small deposits.
Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine with Distinction (Queen Mary, London) · MSc Practical Dermatology (Cardiff) · Global Key Opinion Leader
Ellansé is polycaprolactone microspheres suspended in a gel carrier. The gel gives volume on the day; the collagen the skin builds around the microspheres is what remains — and none of it can be dissolved. Assessed and placed by Dr Sin Yong on Orchard Road, Singapore.
Your assessment
Who you will see: Dr Sin Yong. He performs every assessment and treatment himself.
Not sure which filler you had? Tell us where and when it was done
Take the short filler self-assessment
Related: pore reduction treatment Singapore.
Ellansé in Singapore refers to polycaprolactone (PCL) microspheres in a carboxymethylcellulose gel carrier, used as a collagen biostimulator. The gel gives volume on the day and the skin then builds collagen around the microspheres. Neither can be dissolved, so assessment, including an ultrasound of earlier injections, comes first.
What is normal and what is not after treatment is set out under Ellansé lumps.
Ellansé is a suspension of polycaprolactone microspheres in a carboxymethylcellulose gel. Polycaprolactone is a synthetic polymer with a long history in resorbable sutures and implants; here it is formed into smooth spheres a few tens of microns across, which make up roughly 30% of the syringe. The remaining 70% is the gel that carries them.
The two components do different jobs on different timelines. The gel provides correction on the day, which is why Ellansé is sometimes described as a filler. Over the following weeks the gel is absorbed, and the microspheres that remain act as a scaffold: fibroblasts lay down new collagen around them, and that collagen is what provides the longer-term support. The microspheres themselves break down slowly to carbon dioxide and water.
It is therefore both a filler and a collagen stimulator, in sequence. That is useful, and it is also the source of most of the misunderstanding around it.

“Hyaluronic filler has an undo injection. Sculptra and Ellansé don't.”
Dr Sin YongOn choosing a non-dissolvable product · from his Instagram explainer series
Because the gel gives an immediate correction, Ellansé is the one collagen stimulator that can be judged in the mirror on the day — and that judgement is usually wrong in both directions.
In the first weeks the gel carrier is absorbed and the volume it provided recedes, so a patient who was pleased on the day may believe the result has faded. Over the following months the collagen response builds around the microspheres, so volume returns in a more structural form. The final result is the collagen, not the gel, and it is not the same shape or quantity as what was visible on the day.
That sequence has a practical consequence: the product is dosed for the collagen it will produce, not for the gel it shows. Filling to a pleasing day-one result is how the lower face ends up heavier than intended months later, with no way to take it back.
Hyaluronidase reverses hyaluronic acid filler. It has no action on polycaprolactone or on the carboxymethylcellulose gel that carries it. Once placed, Ellansé is managed, not reversed.

Nodules are described with polycaprolactone as with every biostimulator. They are usually related to placement that is too superficial, to volume concentrated in one spot, or to mobile areas where the product is worked by muscle. Management depends on what the lump is, which is why ultrasound comes before any intervention; a lump that turns out to be previous hyaluronic acid filler is treated very differently from one that is polycaprolactone. What is done about Ellansé lumps is set out on its own page.
This is also why Dr Sin Yong will not place Ellansé over previous filler that has not been mapped. Correction of biostimulator problems from treatment elsewhere is assessed under filler correction.
“The gel you see on day one is not the result. The collagen that replaces it is — and by then it is too late to change your mind.”
Dr Sin YongOn why Ellansé is planned, not previewed
Ellansé is a polycaprolactone filler, and it is usually studied alongside other collagen stimulators. A 2025 systematic review and meta-analysis in the Aesthetic Surgery Journal covered 25 studies of these products. Minor side effects were common, with pain reported by most participants, and nodules developed in about 5%.
In a randomised, blinded trial comparing a polycaprolactone filler with a polynucleotide filler for lines beside the eyes, the polycaprolactone filler was not inferior, and side effects in both groups were mild. The nodule figure matters more for Ellansé than for hyaluronic acid, because it cannot be dissolved. That is the reason for the conservative placement described on this page.
Ellansé rewards depth and punishes spread. Dr Sin Yong places it deep — on the periosteum or in the deep fat compartments where the anatomy allows — in small, deliberate deposits that give the collagen somewhere structural to form, rather than as a sheet in the superficial fat where a firm product shows through thin skin.
The face is treated as a structure, not a surface. The jawline is read as a line from chin to angle, and the temple and lateral cheek are assessed for how they support the lower face before anything is placed lower down. Where the goal is definition, he uses the firmer formulation sparingly and stages it; where the goal is diffuse support in thinner skin, the softer formulation or a different product altogether may be more defensible.
He under-treats at a first visit and reviews once the gel has gone and the collagen has begun to form, because that is the first point at which the real result can be judged.
Ellansé comes in more than one formulation. The grades share the same polycaprolactone microspheres and gel carrier; they differ in how slowly the microspheres resorb, and so how long the collagen scaffold persists. No grade can be dissolved. The table sets the grades against the areas where a firm, non-reversible product is defensible.

| Formulation | How it differs | Where it tends to be considered | What it cannot do | Page |
|---|---|---|---|---|
| Ellansé-S | The shorter-resorbing grade: the microspheres clear sooner, so the scaffold is present for a shorter horizon | Where a shorter scaffold horizon is preferred; the grade is chosen at assessment | Cannot be dissolved; does not suit lips, tear troughs or thin mobile skin | Collagen biostimulators |
| Ellansé-M | The longer-resorbing grade: the microspheres persist longer, so the collagen scaffold does too | Chin, jawline and backs of the hands, where a longer scaffold has been accepted after assessment | Cannot be dissolved; a heavier lower face from over-dosing is managed, not reversed | Hands |
| Radiesse, for comparison | Calcium hydroxylapatite microspheres: immediate volume plus collagen | Chin, jawline and hands for structure; neck and body hyperdiluted | Cannot be dissolved; radio-opaque; not lips, tear troughs or glabella | Radiesse |
| Hyaluronic acid filler, for comparison | A gel that fills on the day and can be broken down with hyaluronidase | The first injectable in an unassessed face; lips and tear troughs | Does not build a collagen scaffold; draws in water | Dermal fillers |
| Sculptra, for comparison | Poly-L-lactic acid with almost no volume on the day, working diffusely | Global deflation treated as a whole | Cannot be dissolved; gives no day-one preview | Sculptra |
Whichever grade is chosen, Dr Sin Yong doses for the collagen it will produce, not the gel seen on the day.

Ellansé is one of several injectables that leave collagen behind, and they are not interchangeable. The question that separates them is what each does on the day, whether it can be reversed, and where Dr Sin Yong uses it.
| Option | What it is | On the day | Can it be dissolved? | Where it tends to fit | Where it is avoided |
|---|---|---|---|---|---|
| Polycaprolactone (this page) | Microspheres in a carboxymethylcellulose gel carrier | Volume from the gel, which is absorbed; collagen forms around the microspheres | No | Small deep deposits for the chin and jawline, after the temple and lateral cheek are assessed; the backs of the hands | Lips, tear troughs, thin mobile skin, over unmapped earlier filler |
| Calcium hydroxylapatite | Microspheres in a gel carrier; used undiluted or hyperdiluted | Undiluted: structure; hyperdiluted: no volume, skin quality | No | Bone support, used sparingly; diluted for skin quality on the neck and hands | Lips and under the eyes |
| Poly-L-lactic acid | Reconstituted powder that acts as a scaffold | No lasting volume of its own | No | Diffuse volume loss in the temples, mid-face and pre-jowl area | Lips and under the eyes |
| Hyaluronic acid filler | Cross-linked hyaluronic acid gel | Volume where it is placed | Yes, with hyaluronidase | Areas where reversibility matters, such as the lips and tear troughs; the chin, sparingly | Faces already heavy with product |
None of these lifts tissue that has descended. Where sagging is the main concern, Dr Sin Yong plans lifting first with the VF Lift – Vertical Facelift and Time Freeze Laser LCLR®, and uses filler only as needed, sparingly. Because three of the four cannot be dissolved, any earlier filler is mapped with ultrasound before anything is added.
It suits structural work in firm tissue: a chin that needs projection, a jawline that needs a cleaner line, temples and lateral cheeks that have hollowed, and the backs of the hands, where the tendons have become visible. It suits a patient who wants some change on the day but is choosing the product for the collagen that follows, and who understands it cannot be reversed.
It does not suit the lips, the tear troughs or the fine lines of thin, mobile skin. It does not lift a descended tissue plane; a jowl is a laxity problem for focused ultrasound or the VF Lift – Vertical Facelift, and adding volume below it makes the jowl heavier. And it is not the right first injectable in a face that has never been assessed; a reversible hyaluronic acid filler is the more forgiving place to start.
Against its neighbours: Sculptra gives almost no volume on the day and works more diffusely; Radiesse is calcium hydroxylapatite, also immediate plus stimulating, and is the one more often diluted for skin quality. Which fits is an anatomical decision.

A face that has been injected more than once often arrives with a complaint that sounds like it needs more product — a heaviness in the lower face, a fullness under the eyes, a lump that has appeared months after the last visit. In Dr Sin Yong's experience the opposite is more often true: the problem is what is already there, and the answer is subtraction, not addition.
So before any further Ellansé is placed, he scans. High-frequency ultrasound shows what material is sitting in the tissue, how deep it is, whether it has migrated, and whether a lump is polycaprolactone, old hyaluronic acid filler, a cyst, or scar. Each of those is managed differently, and two of them are made worse by injecting on top. A scan takes minutes and changes the plan more often than not.
If the scan shows that less is what you need, that is a different procedure with its own planning — see filler correction. If it shows a clean field, Ellansé can be placed with confidence rather than hope. Either way, nothing is added to a face that has not been looked beneath.
The common findings are swelling, bruising and tenderness at the injection sites, and a temporary firmness where the gel sits. Nodules and visible or palpable product are the specific risks of a firm, non-dissolvable material and are discussed above. The serious risks are vascular and attend any injectable placed near facial vessels, which is why depth, plane and anatomical knowledge matter more than the brand on the box.

Polycaprolactone is resorbed by the body over time and the collagen it produced ages with the rest of the face. The change is not lifelong, and no duration quoted to you is a prediction for your anatomy.
The section above covers the areas and goals Ellansé does not suit; this one covers medical reasons. Ellansé is not used in anyone with a known allergy to its components or a history of severe allergic reactions, with autoimmune disease or on immune-modifying treatment, or with a bleeding disorder. It is postponed during pregnancy and breastfeeding, and wherever there is infection or inflammation at or near the injection site, such as active acne or a cold sore.
It is not placed over non-absorbable filler such as silicone, or over any previous filler that has not been identified, which is why an ultrasound scan comes first. Blood-thinning medicines, a tendency to keloid or hypertrophic scarring, and recent or planned dental work call for caution or a change of timing. Because neither the polycaprolactone nor its gel carrier can be dissolved with hyaluronidase, anyone who wants a result that can be reversed should choose a hyaluronic acid filler instead. Suitability is decided at consultation, after Dr Sin Yong has taken a medical history and examined the area.

The sequence below describes phases, not a timetable: how quickly each passes depends on the settings used, the area and the person, and is discussed at consultation.
People who want lips or tear troughs treated, expect a lift of a sagging jowl, or want a fully reversible option tend to respond poorly, because Ellansé is a non-reversible structural tool.
The fee depends on the areas treated, the formulation chosen, the amount of product your anatomy calls for, whether treatment is staged with review once the gel has gone, and whether it is combined with another treatment. The plan is set after assessment rather than as a fixed course. A written quote is given at consultation, and the consultation also decides whether Ellansé is advised at all, or whether a reversible filler or a different approach would suit you better.
How quotes work at this practice: how we quote.
Most people feel pressure and some stinging as each deposit is placed, rather than sharp pain. Ellansé is placed deep, on the bone or in the deep fat, and areas close to bone can feel more noticeable. Numbing cream can be applied first. How it feels depends on the area and individual sensitivity. Tell Dr Sin Yong if it is uncomfortable, and the pace is adjusted.
No. Ellansé adds volume from its gel and then collagen around the microspheres, which can define bone support, but it does not lift tissue that has descended. Adding product to a sagging lower face can make it heavier. Dr Sin Yong treats laxity first with the VF Lift – Vertical Facelift and Time Freeze Laser LCLR®, and considers small, deep deposits only where structural support is still missing afterwards.
The gel is absorbed within weeks and the lasting result is the collagen that forms, which differs in shape and quantity.
Hyaluronidase has no action on polycaprolactone or its gel carrier, so a misplaced result is managed, not reversed.
Every treatment is performed by Dr Sin Yong personally. Singapore Medical Council registered · invited to share his clinical expertise internationally as a Key Opinion Leader for CLASSYS, DEKA, HIRONIC, FOTONA, ALMA, LUTRONIC and ILOODA · HSA-registered devices · ultrasound-guided correction
Dr Sin Yong's aesthetic clinic in Singapore is on Orchard Road, a short walk from Orchard MRT. More about the aesthetic doctor in Singapore who performs every treatment.
WhatsApp Dr Sin Yong →or use the enquiry formRelated
Product page: Sculptra — how PLLA works, who it suits, what sets the fee.
Ellansé is polycaprolactone and cannot be dissolved with hyaluronidase. A lump is examined, often with ultrasound, to see whether it is product, inflammation or tissue response. Options range from observation and injections to Time Freeze Laser LCLR® in its Sculpting mode, which Dr Sin Yong uses to target the excess.
Ellansé cannot be dissolved with hyaluronidase. A nodule is examined and mapped with ultrasound to show what it is likely to be and how deep it sits. Inflammatory nodules are managed medically; firm over-stimulated areas are treated with Time Freeze Laser LCLR®, which is built to target the excess tissue response. See the non-HA filler lumps page.
An overfilled look comes from too much product or the wrong layer. Because Ellansé cannot be dissolved, Dr Sin Yong plans conservative amounts in the deep structural layers and reviews before adding more. The early fullness from the gel carrier settles as it is absorbed.
Yes. 少女针 (literally “young-girl injection”) is a Chinese nickname for Ellansé, the polycaprolactone (PCL) collagen stimulator, often written Ellanse. The nickname is marketing shorthand; it does not mean the treatment suits younger patients or gives a particular look.
It is a good choice for some faces and the wrong one for others. Ellansé (Ellanse) is a polycaprolactone filler that also stimulates collagen, so it suits structural support such as the jawline, chin and temples in someone happy with a longer-lasting product. It cannot be dissolved like hyaluronic acid, so it is not used in the lips or under the eyes, and placement is deliberately conservative.
Ellansé, often typed as Ellanse, is a polycaprolactone (PCL) filler: its gel gives immediate support while the microspheres stimulate the body's own collagen as the product slowly absorbs. Doctors in Singapore use it where structure is needed, such as the temples, cheeks, chin and jawline. It cannot be dissolved with hyaluronidase, so the dose and placement are planned conservatively.
Question not answered here? Ask on WhatsApp, use the enquiry form, or browse 100 questions patients ask.
Christen MO, Vercesi F. Polycaprolactone: how a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clinical, Cosmetic and Investigational Dermatology 2020;13:31–48. source
de Melo F, Nicolau P, Piovano L, et al. Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®). Clinical, Cosmetic and Investigational Dermatology 2017;10:431–440. source
Wortsman X. Identification and complications of cosmetic fillers: sonography first. Journal of Ultrasound in Medicine 2015;34(7):1163–1172. source
Health Sciences Authority. Infosearch — register of health products and medical devices approved for supply in Singapore. source
Singapore Medical Council. Guidelines on Aesthetic Practices for Doctors, 2016 Edition. source
Smith L, Rahmati M, Pizzol D, López-Sánchez GF, Boyer L, Fond G, et al. Biostimulants in Aesthetic Medicine: A Systematic Review and Meta-analysis of Efficacy, Safety, and Patient Satisfaction. Aesthetic Surgery Journal, 2025. doi.org
Choi SY, Koh YG, Yoo KH, Han HS, Seok J, Kim BJ. A Randomized, Participant- and Evaluator-Blinded, Matched-Pair, Prospective Study Comparing the Safety and Efficacy Between Polycaprolactone and Polynucleotide Fillers in the Correction of Crow's Feet. Journal of Cosmetic Dermatology, 2025. doi.org
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last updated 6 November 2026 · Editorial policy
Whether a firm, non-dissolvable biostimulator is the right answer depends on the structure of your face and on what has been injected before. Dr Sin Yong assesses that first.
Arrange a consultation